Suchergebnisse - "Hueppe, Dietrich"

1

Sa1034 Sustained Responders After Antiviral Treatment of Chronic Hepatitis C Have a Better Quality of Life and Productivity Independent of Genotype, Age and Opioid Maintenance

von: Mauss, Stefan

2013, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
2

723 Substantial Renal Impairment Is Not Infrequent in HCV Patients Under Triple Therapy With Telaprevir or Boceprevir

von: Mauss, Stefan

2013, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
3

Sa1041 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) and Boceprevir (BOC) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1. the PAN Study

von: Moog, Gero

2013, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
4

Sa1051 Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1: An Interim Analysis At Week 12 After Start of Treatment

von: Moog, Gero

2013, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
5

Sa1050 Efficacy of Boceprevir Based Triple Therapy in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) Under Real Life Conditions in Treatment Experienced Patients Infected With Chronic Hepatitis C, Genotype 1: The PAN Study

von: Moog, Gero

2013, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
6

Sa1052 Triple Therapy Under Real Life Conditions: Telaprevir (TVR) in Combination With Peginterferon-Alfa-2A Plus Ribavirin (P/R) in NaïVE Patients Infected With Chronic Hepatitis C, Genotype 1. The PAN Study

von: Moog, Gero

2013, in: Ubiquitin protease Ubp8 is necessary for

Wird geladen...
7

Effectiveness and Safety of Tenofovir Disoproxil Fumarate in Chronic Hepatitis B: A 3-Year Prospective Field Practice Study in Germany

von: Petersen, Jörg

2015, in: Digestive diseases and sciences

Wird geladen...

Nicht das Richtige dabei?

Schreiben Sie uns!